Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.
 BACK TO LIST

Laboratory Report

Patient
Name: Taylor, , Eileen,
DOB: 11-DEC-1951 (Age: 73)
Gender: female
Address:
39 Slater harbors
LE17 Smithtown (United Kingdom)
ID: 6172-576075-7 (ECI)
Report
Date: 11-APR-2022
Laboratory
dr Ample, Ex
Laboratoire Central Européenne
Boulevard du Jardin Botanique 32
1000 Brussels (Belgium)
Requested by
Leicester Royal Infirmary
LE2 7 Leicester (United Kingdom)
Specimen
Collected: 11-APR-2022

Chemistry

Test 11-APR-2022 Reference Range Unit
Cholesterol [Mass/volume] in Serum or Plasma 162.3 130 - 200 mg/dL
Triglyceride [Mass/volume] in Serum or Plasma 142.8 35 - 175 mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay 86.0 0 - 190 mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma 47.7 L 50 - 100 mg/dL

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
Lipid profile is within normal limits except for a mildly decreased HDL cholesterol. Low HDL is a cardiovascular risk factor; consider lifestyle modifications such as increased physical activity and dietary changes. No other lipid abnormalities detected. Correlate with clinical context and other risk factors.